Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia

키워드

참고문헌 (77)

1. O’Brien JT, "Vascular dementia", Lancet, 386, pp.1698~1706 (2015)
2. Wang J, "Cholinergic deficiency involved in vascular dementia : possible mechanism and strategy of treatment", Acta Pharmacol Sin, 30, pp.879~888 (2009)
3. de la Monte SM, "Alzheimer’s disease is type 3 diabetes-evidence reviewed", J Diabetes Sci Technol, 2, pp.1101~1113 (2008)
4. Ravona-Springer R, "The association of diabetes and dementia and possible implications for nondiabetic populations", Expert Rev Neurother, 11, pp.1609~1617 (2011)
5. Prasad S, "Diabetes mellitus and blood-brain barrier dysfunction : an overview", J Pharmacovigil, 2, pp.125~ (2014)
6. Arnold SE, "Brain insulin resistance in type 2diabetes and Alzheimer disease : concepts and conundrums", Nat Rev Neurol, 14, pp.168~181 (2018)
7. Murtishaw AS, "Intermittent streptozotocin administration induces behavioral and pathological features relevant to Alzheimer’s disease and vascular dementia", Neuropharmacology, 137, pp.164~177 (2018)
8. Sharma B, "Pitavastatin and 4’-hydroxy-3’-methoxyacetophenone(HMAP)reduce cognitive dysfunction in vascular dementia during experimental diabetes", Curr Neurovasc Res, 7, pp.180~191 (2010)
9. Sharma B, "Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats", Psychopharmacology(Berl), 215, pp.677~687 (2011)
10. Sharma B, "Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats", Pharmacol Biochem Behav, 100, pp.320~329 (2011)
11. Singh G, "Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats", Pharmacol Biochem Behav, 124, pp.27~35 (2014)
12. Liu M, "Effect of ulinastatin on the permeability of the blood-brain barrier on rats with global cerebral ischemia", reperfusion injury as assessed by MRI, 2017, pp.85, 412~417
13. Ma L, "Ulinastatin decreases permeability of blood--brain barrier by inhibiting expression of MMP-9 and t-PA in postoperative aged rats", Int J Neurosci, 126, pp.463~468 (2016)
14. Cui T, "Ulinastatin attenuates brain edema after traumatic brain injury in rats", Cell Biochem Biophys, 71, pp.595~600 (2015)
15. Li XF, "Ulinastatin protects brain against cerebral ischemia", reperfusion injury through inhibiting MMP-9 and alleviating loss of ZO-1 and occludin proteins in mice, 2018, pp.302, 68~74
16. Guo M, "Ulinastatin attenuates isoflurane-induced cognitive dysfunction in aged rats by inhibiting neuroinflammation and -amyloid peptide expression in the brain", Neurol Res, 41, pp.923~929 (2019)
17. Inagaki T, "Changes in the ratio of urinary alpha 1-microglobulin to ulinastatin levels in patients with psychiatric diseases", Biol Psychiatry, 40, pp.800~803 (1996)
18. Cao LJ, "Effects of ulinastatin, a urinary trypsin inhibitor, on synaptic plasticity and spatial memory in a rat model of cerebral ischemia", reperfusion injury, 2011, pp.54, 435~442
19. Zhang M, "Ulinastatin may significantly improve postoperative cognitive function of elderly patients undergoing spinal surgery by reducing the translocation of lipopolysaccharide and systemic inflammation", Front Pharmacol, 9, pp.1007~ (2018)
20. Koga Y, "Urinary trypsin inhibitor suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia", reperfusion rats, 2010, pp.32, 925~932
21. Hu CL, "Ulinastatin attenuates oxidation, inflammation and neural apoptosis in the cerebral cortex of adult rats with ventricular fibrillation after cardiopulmonary resuscitation", Clinics(Sao Paulo), 68, pp.1231~1238 (2013)
22. Xie X, "Protective effects of Ulinastatin on oxidative stress and inflammation of rat-derived cardiomyocytes H9c2", Am J Transl Res, 11, pp.7094~7103 (2019)
23. Jazwa A, "Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism", Antioxid Redox Signal, 14, pp.2347~2360 (2011)
24. Huang C, "Effects of sulforaphane in the central nervous system", Eur J Pharmacol, 853, pp.153~168 (2019)
25. Akihiro Shiina, "An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia", Clinical Psychopharmacology and Neuroscience, 13(1), pp.62~67 (2015), 대한정신약물학회
26. Axelsson AS, "Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2diabetes", Sci Transl Med, 9, pp.eaah4477~ (2017)
27. Gao J, "Sulforaphane alleviates lipopolysaccharide-induced spatial learning and memory dysfunction in mice : the role of BDNFmTOR signaling pathway", Neuroscience, 388, pp.357~366 (2018)
28. Ibbotson K, "Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress", Fluids Barriers CNS, 14, pp.6~ (2017)
29. Jang M, "Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the Keap1-Nrf2-ARE pathway and inhibiting the MAPKs and NF-B pathways", Mol Neurobiol, 53, pp.2619~2635 (2016)
30. Zhou Q, "Sulforaphane protects against rotenone-induced neurotoxicity in vivo : Involvement of the mTOR, Nrf2, and autophagy pathways", Sci Rep, 6, pp.32206~ (2016)
31. Townsend BE, "Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice", Exp Gerontol, 73, pp.42~48 (2016)
32. Lee S, "Sulforaphane alleviates scopolamine-induced memory impairment in mice", Pharmacol Res, 85, pp.23~32 (2014)
33. Wang G, "Sulforaphane prevents neuronal apoptosis and memory impairment in diabetic rats", Cell Physiol Biochem, 39, pp.901~907 (2016)
34. Jain S, "Effect of ruthenium red, a ryanodine receptor antagonist in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats", Physiol Behav, 164(Pt A), pp.140~150 (2016)
35. Jain S, "Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia", Physiol Behav, 152(Pt A), pp.182~193 (2015)
36. Sharma P, "Possible involvement of D2", D3 receptor activation in ischemic preconditioning mediated protection of the brain, 2020, pp.1748, 147116~
37. Reddy SS, "Implication of altered ubiquitin-proteasome system and ER stress in the muscle atrophy of diabetic rats", Arch Biochem Biophys, 639, pp.16~25 (2018)
38. Tekula S, "Withaferin-A attenuates multiple low doses of Streptozotocin(MLD-STZ)induced type 1 diabetes", Biomed Pharmacother, 106, pp.1428~1440 (2018)
39. Gupta S, "Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington’s disease", Pharmacol Biochem Behav, 122, pp.122~135 (2014)
40. Mirza R, "Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor- agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats", Int J Dev Neurosci, 76, pp.6~16 (2019)
41. Matsumura Y, "Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension", Circulation, 102, pp.2765~2773 (2000)
42. Howarth FC, "Long-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats", Exp Physiol, 90, pp.827~835 (2005)
43. Kennedy DO, "B Vitamins and the brain : mechanisms, dose and efficacy--a review", Nutrients, 8, pp.68~ (2016)
44. Natali A, "Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes", Diabetes, 55, pp.1133~1140 (2006)
45. Maryam Safavi, "Protective Effects of Citicoline and Benfotiamine Each Alone and in Combination on Streptozotocin-induced Memory Impairment in Mice", Clinical Psychopharmacology and Neuroscience, 18(1), pp.81~92 (2020), 대한정신약물학회[DOI]
46. Guzik TJ, "Mechanisms of increased vascular superoxide production in human diabetes mellitus : role of NAD(P)H oxidase and endothelial nitric oxide synthase", Circulation, 105, pp.1656~1662 (2002)
47. Ighodaro OM, "First line defence antioxidantssuperoxide dismutase(SOD), catalase(CAT)and glutathione peroxidase(GPX) : Their fundamental role in the entire antioxidant defence grid", Alex J Med, 54, pp.287~293 (2018)
48. Muriach M, "Diabetes and the brain : oxidative stress, inflammation, and autophagy", Oxid Med Cell Longev, 2014, pp.102158~ (2014)
49. Armogida M, "The protective role of catalase against cerebral ischemia in vitro and in vivo", Int J Immunopathol Pharmacol, 24, pp.735~747 (2011)
50. Patel H, "Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC", Cardiovasc Diabetol, 12, pp.142~ (2013)
51. Hop HT, "Activation of NF-kB-mediated TNF-induced antimicrobial immunity is required for the efficient Brucella abortus clearance in RAW 264.7 cells", Front Cell Infect Microbiol, 7, pp.437~ (2017)
52. Catrysse L, "Inflammation and the metabolic syndrome: the tissue-specific functions of NF-κB", Trends Cell Biol, 27, pp.417~429 (2017)
53. Zhao G, "The effect of ulinastatin on hyperglycemia in patients undergoing hepatectomy", J Surg Res, 193, pp.223~228 (2015)
54. Liang S, "Ulinastatin reduces the severity of intestinal damage in the neonatal rat model of necrotizing enterocolitis", Med Sci Monit, 25, pp.9123~9130 (2019)
55. Wang WK, "Ulinastatin attenuates diabetes-induced cardiac dysfunction by the inhibition of inflammation and apoptosis", Exp Ther Med, 14, pp.2497~2504 (2017)
56. Honda Y, "A case of successful treatment of a patient with hyperglycemia of 2700mg", dL, 2012, pp.30, 254~
57. Yano T, "Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats", Anesthesiology, 98, pp.465~473 (2003)
58. Zhao J, "Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice", Sci Rep, 9, pp.5790~ (2019)
59. Shikimi T, "Existence of a human urinary trypsin inhibitor(urinastatin)-like substance in the rat brain", Jpn J Pharmacol, 60, pp.97~103 (1992)
60. Li Y, "Ulinastatin suppresses lipopolysaccharide induced neuro-inflammation through the downregulation of nuclear factor-B in SD rat hippocampal astrocyte", Biochem Biophys Res Commun, 458, pp.763~770 (2015)
61. Guo W, "Urinary Trypsin Inhibitor attenuates acute lung injury by improving endothelial progenitor cells functions", Cell Physiol Biochem, 36, pp.1059~1068 (2015)
62. Li G, "Ulinastatin inhibits oxidant-induced endothelial hyperpermeability and apoptotic signaling", Int J Clin Exp Pathol, 7, pp.7342~7350 (2014)
63. Kudo Y, "Protective effect of ulinastatin against liver injury caused by ischemia-reperfusion in rats", Jpn J Pharmacol, 60, pp.239~245 (1992)
64. Liu B, "Neuroprotective effect of ulinastatin on spinal cord ischemia-reperfusion injury in rabbits", Oxid Med Cell Longev, 2015, pp.624819~ (2015)
65. Song F, "Ulinastatin protects against CVB3-induced acute viral myocarditis through Nrf2activation", Inflammation, 41, pp.803~810 (2018)
66. Wang S, "Ulinastatin protects rats with myocardial infarction by activating Nrf2", NOS pathway, 2018, pp.22, 8990~8998
67. Li X, "Ulinastatin downregulates TLR4 and NF-kB expression and protects mouse brains against ischemia", reperfusion injury, 2017, pp.39, 367~373
68. Lee JH, "Sulforaphane-induced autophagy flux prevents prion protein-mediated neurotoxicity through AMPK pathway", Neuroscience, 278, pp.31~39 (2014)
69. Mao L, "Protective effects of sulforaphane in experimental vascular cognitive impairment : Contribution of the Nrf2 pathway", J Cereb Blood Flow Metab, 39, pp.352~366 (2019)
70. "Broccoli for enhanced learning, memory, cognition and longevity: sulforaphane from broccoli functions as a learning/memory/cognitive/longevity-enhancer: sulforaphane, isolated from broccoli among others, increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down regulation of its target genes" (2018)[URL]
71. Negi G, "Nrf2 and NF-B modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes", Curr Neurovasc Res, 8, pp.294~304 (2011)
72. Shehatou GS, "Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits", Exp Biol Med(Maywood), 241, pp.426~436 (2016)
73. Sotokawauchi A, "Aqueous extract of glucoraphanin-rich broccoli sprouts inhibits formation of advanced glycation end products and attenuates inflammatory reactions in endothelial cells", Evid Based Complement Alternat Med, 2018, pp.9823141~ (2018)
74. Uddin MS, "Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders", Sci Total Environ, 707, pp.135624~ (2020)
75. Itoh K, "An Nrf2", small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements, 1997, pp.236, 313~322
76. Imhoff BR, "Extracellular redox status regulates Nrf2 activation through mitochondrial reactive oxygen species", Biochem J, 424, pp.491~500 (2009)
77. Birks JS, "Donepezil for dementia due to Alzheimer’s disease", Cochrane Database Syst Rev, 6, pp.CD001190~ (2018)

관련 논문AI추천